Seres Therapeutics Inc (NASDAQ:MCRB)
| 3.04 Delayed Data As of May 24 |  -0.265 / -8.03%Today’s Change | 2.97 Today|||52-Week Range 25.06 | -63.57% Year-to-Date |
Latest MCRB News | Press Releases
No recent news for Seres Therapeutics Inc.
Today’s Trading
| Previous close | 3.30 |
| Today’s open | 3.22 |
| Day’s range | 2.99 - 3.22 |
| Volume | 31,581 |
| Average volume (3 months) | 796,787 |
| Market cap | $332.0M |
Data as of 4:00pm ET, 05/24/2022
Growth & Valuation
| Earnings growth (last year) | +35.98% |
| Earnings growth (this year) | -223.96% |
| Earnings growth (next 5 years) | -4.75% |
| Revenue growth (last year) | +336.33% |
| P/E ratio | NM |
| Price/Sales | 5.27 |
| Price/Book | 2.49 |
Competitors
| ---- | ||
| XXII22nd Century Group I... | -0.07 | -4.21% |
| RDUSRadius Health Inc | -0.11 | -1.82% |
| MRSNMersana Therapeutics... | -0.10 | -2.98% |
Data as of 4:00pm ET, 05/24/2022
Financials
| Next reporting date | August 4, 2022 |
| EPS forecast (this quarter) | -$0.60 |
| Annual revenue (last year) | $144.9M |
| Annual profit (last year) | -$65.6M |
| Net profit margin | -45.25% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
